08042025 Vadodara Gujarat, SNH Innovation LLP:
- What are the side effects of Cancer treatment?
- Will the treatment be effective for my type and stage of cancer?
- How will cancer treatment impact my quality of life?
- Are there alternative or less invasive treatment options available?
- What are the costs and financial implications of cancer treatment
Cancer remains a significant public health challenge in India, with an estimated 1.3 million new cases diagnosed annually. The disease’s prevalence is alarming, with approximately 2.7 million individuals living with cancer at any given time.
Common types include breast, cervical, oral, and lung cancers, which account for a substantial portion of cases. Despite advancements in treatment, late diagnosis and limited access to affordable care often hinder effective management.
This article delves into the groundbreaking work of a Gujarat based StartUp, a pioneer in developing life-changing therapies to combat cancer.
SNH Innovation LLP is on a revolutionary mission to eradicate cancer through innovative Nanoparticulate-based Antibody Drug Conjugates (NADCs). By leveraging the precision of monoclonal antibodies, their groundbreaking immunotherapies ensure cytotoxic drugs are directly targeted to cancerous tumor cells, sparing healthy cells and minimizing adverse effects.
Innovative approaches, such as targeted therapies and immunotherapies, are transforming cancer care. These treatments aim to improve precision, reduce side effects, and enhance patient outcomes. By leveraging cutting-edge technologies like nanoparticulate-based antibody drug conjugates (NADCs), there is hope for a future where cancer treatment is safer, more effective, and widely accessible.
The proprietary platform technology sets a new benchmark in cancer treatment, improving the therapeutic index of cytotoxic payloads compared to conventional therapies. Here’s how:
Nanoparticles: Deliver enhanced bioavailability, superior stability, high drug-loading capacity, and precise targeting to specific body sites.
ADC Linkers: Ensure payload safety with stable linkers that release cytotoxic drugs only upon reaching tumor cells, limiting systemic exposure.
Monoclonal Antibodies: Smartly bind to antigens predominantly found on cancer cells, ensuring higher tumor selectivity and reduced side effects.
With NADCs, they amplify the tumor-killing potential of monoclonal antibodies, enhancing drug tolerability and offering life-changing solutions to patients worldwide. SNH Innovation LLP is pioneering a future where cancer treatment is both safer and more effective.
Together, let’s redefine cancer care!
Dr. Nirav Chauhan is the visionary founder of SNH Innovation LLP, a DIPP-recognized StartUp dedicated to developing novel nanoparticulate-based antibody drug conjugates. His remarkable entrepreneurial journey has been marked by prestigious accolades, including the Gold Award from the Vadodara Innovation Council, the GTU SSIP Grant, and the title of Best Student StartUp by Gujarat Technological University (GTU).
Under his leadership, SNH Innovation LLP has earned recognition through the Biotech Policy of the Government of Gujarat and has been awarded the StartUp India Seed Fund from the Government of India. Dr. Nirav Chauhan holds a Ph.D. in Pharmaceutical Technology from Gujarat Technological University, as well as a Master’s and Bachelor’s degree in pharmacy from M.S. University, Vadodara.
With a profound understanding of scientific principles, intellectual property rights (IPR), Dr. Nirav Chauhan seamlessly integrates his expertise into practical and entrepreneurial endeavors, driving groundbreaking innovations in cancer care.
Way2World invites you to follow our pages on Facebook and LinkedIn. #Way2World provides insights and news regarding #Founders, #Co-Founders, #WomenEntrepreneurs, #WomenLeaders, #Mentors, #Innovation, #Incubators, #Accelerators, and #Listing. Our #Articles, #Reviews, and #Stories explore topics related to #Funding, #IndianStartUps, their #BusinessServices, as well as the impact of #Technology. Please note that this content, including images, is generated with the assistance of AI tools and is intended solely for informational purposes regarding current trends. It is not a recommendation. We advise conducting thorough analyses tailored to your specific needs and consulting with experts in the field. Content includes contributions from the Internet – RajKishan Ganta.
DISCLAIMER: The information presented in this news item is intended solely for informational purposes and should not be interpreted as professional advice, legal opinion, or endorsement by WAY2WORLD.
We cannot guarantee the accuracy, completeness, or timeliness of the information provided. WAY2WORLD and its affiliates disclaim any liability for errors, omissions, or damages resulting from reliance on this content.
Readers are strongly encouraged to verify information through multiple sources and to consult with qualified professionals before making decisions based on this material.
The views expressed in this news item reflect the opinions of the author(s) and do not necessarily represent those of WAY2WORLD or its affiliates.
WAY2WORLD does not endorse or promote any specific product, service, or organization mentioned herein unless explicitly stated. We urge readers to exercise their discretion and judgment when interpreting and applying the information.
Comments made in this space do not represent the views of WAY2WORLD. Individuals posting comments assume full responsibility for their content. In accordance with Central Government IT regulations, any obscene or offensive statements against individuals, religions, communities, or nations are punishable offenses and legal action may be pursued against violators.